UniProt ID | CACB4_HUMAN | |
---|---|---|
UniProt AC | O00305 | |
Protein Name | Voltage-dependent L-type calcium channel subunit beta-4 {ECO:0000305} | |
Gene Name | CACNB4 {ECO:0000312|HGNC:HGNC:1404} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 520 | |
Subcellular Localization | ||
Protein Description | The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting.. | |
Protein Sequence | MSSSSYAKNGTADGPHSPTSQVARGTTTRRSRLKRSDGSTTSTSFILRQGSADSYTSRPSDSDVSLEEDREAIRQEREQQAAIQLERAKSKPVAFAVKTNVSYCGALDEDVPVPSTAISFDAKDFLHIKEKYNNDWWIGRLVKEGCEIGFIPSPLRLENIRIQQEQKRGRFHGGKSSGNSSSSLGEMVSGTFRATPTSTAKQKQKVTEHIPPYDVVPSMRPVVLVGPSLKGYEVTDMMQKALFDFLKHRFDGRISITRVTADISLAKRSVLNNPSKRAIIERSNTRSSLAEVQSEIERIFELARSLQLVVLDADTINHPAQLIKTSLAPIIVHVKVSSPKVLQRLIKSRGKSQSKHLNVQLVAADKLAQCPPEMFDVILDENQLEDACEHLGEYLEAYWRATHTTSSTPMTPLLGRNLGSTALSPYPTAISGLQSQRMRHSNHSTENSPIERRSLMTSDENYHNERARKSRNRLSSSSQHSRDHYPLVEEDYPDSYQDTYKPHRNRGSPGGYSHDSRHRL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSSSSYAKN ------CCCHHCCCC | 38.64 | 22210691 | |
3 | Phosphorylation | -----MSSSSYAKNG -----CCCHHCCCCC | 23.23 | 22210691 | |
11 | Phosphorylation | SSYAKNGTADGPHSP HHCCCCCCCCCCCCC | 30.85 | - | |
13 (in isoform 2) | Phosphorylation | - | 71.62 | 22210691 | |
21 (in isoform 2) | Phosphorylation | - | 35.05 | 22210691 | |
39 | Phosphorylation | RLKRSDGSTTSTSFI HCCCCCCCCCCCEEE | 33.24 | - | |
51 | Phosphorylation | SFILRQGSADSYTSR EEEEECCCCCCCCCC | 22.14 | 23312004 | |
54 | Phosphorylation | LRQGSADSYTSRPSD EECCCCCCCCCCCCC | 29.99 | 23312004 | |
55 | Phosphorylation | RQGSADSYTSRPSDS ECCCCCCCCCCCCCC | 14.85 | 23312004 | |
56 | Phosphorylation | QGSADSYTSRPSDSD CCCCCCCCCCCCCCC | 23.39 | 23312004 | |
57 | Phosphorylation | GSADSYTSRPSDSDV CCCCCCCCCCCCCCC | 33.68 | 23312004 | |
60 | Phosphorylation | DSYTSRPSDSDVSLE CCCCCCCCCCCCCHH | 48.95 | 23312004 | |
62 | Phosphorylation | YTSRPSDSDVSLEED CCCCCCCCCCCHHHH | 44.22 | 23312004 | |
65 | Phosphorylation | RPSDSDVSLEEDREA CCCCCCCCHHHHHHH | 34.75 | 23312004 | |
99 | Phosphorylation | PVAFAVKTNVSYCGA CEEEEEECCCCCCCC | 33.96 | 18220336 | |
102 | Phosphorylation | FAVKTNVSYCGALDE EEEECCCCCCCCCCC | 19.44 | 18220336 | |
103 | Phosphorylation | AVKTNVSYCGALDED EEECCCCCCCCCCCC | 7.22 | 18220336 | |
180 | Phosphorylation | GGKSSGNSSSSLGEM CCCCCCCCCCCHHHH | 34.81 | - | |
182 | Phosphorylation | KSSGNSSSSLGEMVS CCCCCCCCCHHHHHC | 29.42 | - | |
183 | Phosphorylation | SSGNSSSSLGEMVSG CCCCCCCCHHHHHCC | 42.20 | - | |
207 | Phosphorylation | AKQKQKVTEHIPPYD HHHHHHCCCCCCCCC | 28.96 | 24719451 | |
213 | Phosphorylation | VTEHIPPYDVVPSMR CCCCCCCCCCCCCCC | 18.93 | - | |
218 | Phosphorylation | PPYDVVPSMRPVVLV CCCCCCCCCCCEEEE | 18.80 | 24275569 | |
228 | Phosphorylation | PVVLVGPSLKGYEVT CEEEECCCCCCCCHH | 36.46 | 24275569 | |
232 | Phosphorylation | VGPSLKGYEVTDMMQ ECCCCCCCCHHHHHH | 12.97 | 24275569 | |
235 | Phosphorylation | SLKGYEVTDMMQKAL CCCCCCHHHHHHHHH | 13.26 | 24275569 | |
255 | Phosphorylation | HRFDGRISITRVTAD HHCCCCCEEEEEECC | 19.29 | 24719451 | |
257 | Phosphorylation | FDGRISITRVTADIS CCCCCEEEEEECCHH | 16.58 | 23312004 | |
260 | Phosphorylation | RISITRVTADISLAK CCEEEEEECCHHHHH | 18.47 | 23312004 | |
264 | Phosphorylation | TRVTADISLAKRSVL EEEECCHHHHHHHHH | 23.87 | 29083192 | |
276 | Acetylation | SVLNNPSKRAIIERS HHHCCHHHHHHHHCC | 47.29 | 21466224 | |
337 | Phosphorylation | IIVHVKVSSPKVLQR EEEEEECCCHHHHHH | 34.89 | 24719451 | |
411 | Phosphorylation | TTSSTPMTPLLGRNL CCCCCCCCCCCCCCC | 16.40 | 24076635 | |
421 | Phosphorylation | LGRNLGSTALSPYPT CCCCCCCCCCCCCCC | 29.80 | - | |
435 | Phosphorylation | TAISGLQSQRMRHSN CHHHHHHHHHHHCCC | 25.46 | - | |
448 | Phosphorylation | SNHSTENSPIERRSL CCCCCCCCHHHHHHC | 22.48 | - | |
476 | Phosphorylation | KSRNRLSSSSQHSRD HHHHHHCCCCCCCCC | 38.30 | 21712546 | |
477 | Phosphorylation | SRNRLSSSSQHSRDH HHHHHCCCCCCCCCC | 30.55 | 21712546 | |
481 | Phosphorylation | LSSSSQHSRDHYPLV HCCCCCCCCCCCCCC | 31.59 | 21712546 | |
499 | Phosphorylation | YPDSYQDTYKPHRNR CCCCCCCCCCCCCCC | 20.23 | - | |
500 | Phosphorylation | PDSYQDTYKPHRNRG CCCCCCCCCCCCCCC | 30.71 | - | |
506 | Methylation | TYKPHRNRGSPGGYS CCCCCCCCCCCCCCC | 47.09 | - | |
508 | Phosphorylation | KPHRNRGSPGGYSHD CCCCCCCCCCCCCCC | 19.68 | - | |
512 | Phosphorylation | NRGSPGGYSHDSRHR CCCCCCCCCCCCCCC | 14.56 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CACB4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CACB4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CACB4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBL3_HUMAN | TBL3 | physical | 16169070 | |
MED31_HUMAN | MED31 | physical | 16169070 | |
PTN_HUMAN | PTN | physical | 16169070 | |
CAC1A_HUMAN | CACNA1A | physical | 10212211 | |
CBX3_HUMAN | CBX3 | physical | 21220418 | |
CACB3_HUMAN | CACNB3 | physical | 28514442 | |
GT252_HUMAN | COLGALT2 | physical | 28514442 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
607682 | Epilepsy, idiopathic generalized 9 (EIG9) |
607682 | Juvenile myoclonic epilepsy 6 (EJM6) |
613855 | Episodic ataxia 5 (EA5) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB04855 | Dronedarone |
DB00393 | Nimodipine |
DB00421 | Spironolactone |
DB00661 | Verapamil |
loading...